DTC Ads Remain Controversial Despite Positive Study Results, PhRMA Says
The Pharmaceutical Research & Manufacturers of America is prepared to use the results of recent direct-to-consumer advertising studies to respond to critics of the marketing practice
You may also be interested in...
GlaxoSmithKline is selling its products direct to pharmacies in Canada that are suspected by the company of selling to consumers in the U.S
The generic industry should consider carefully any attempt to derail FDA's regulatory approach to Waxman/Hatch reform, agency Chief Counsel Daniel Troy told the Generic Pharmaceutical Association
FDA expects to publish a report on its 1997 direct-to-consumer broadcast advertising policy this spring